Ishan Dyes and Chemicals profit and loss

Latest FY26

Revenue: ₹73.5cr−27.6% on FY25
EBITDA: ₹3.7cr−44.3% on FY25
Net profit: −₹7.1cr₹1.1 cr in FY25
EPS: −₹6.00₹0.52 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025

Expenses
	112	73.5	101
	4.5	3.2	3.0
	117	76.6	104
	91.3	48.5	69.1
	−16.1	2.4	−6.1
	8.1	8.2	8.4
	9.1	7.0	5.1
	7.7	4.8	2.5
	11.6	10.6	23.3
	112	81.6	102
	17.5	3.7	6.7
	9.7	−1.1	4.2
Profit
	5.0	−5.0	2.1
	5.0	−5.0	2.1
	0.0	0.0	1.3
	2.4	2.1	−0.2
	2.5	2.1	1.0
	2.6	−7.1	1.1
	2.6	−7.1	1.1
	0.1	0.1	−0.0
	2.7	−7.0	1.1
Per share
	₹1.45	−₹6.00	₹0.52
	₹1.45	−₹5.98	₹0.52
Other comprehensive income — detail
	—	0.1	−0.0
	—	—	0.0
	—	−0.1	—
Per share — as-filed variants
	₹0.89	−₹3.00	₹0.52
	₹0.89	−₹2.99	₹0.52
	₹0.56	−₹3.00	₹0.00
	₹0.56	−₹2.99	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	37.1	22.6	38.4
	33.0%	30.7%	37.9%
Adjusted (ex-exceptional items) — derived
	5.0	−5.0	2.1
	2.6	−7.1	1.1
	₹1.45	−₹6.00	₹0.52

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ISHANCH₹43.97

Ishan Dyes and Chemicals Limited

· Chemicals

Annual Quarterly₹ CrorePeersHPIL VIKASECO CHEMBOND DIAMINESQ ACI AETHER ALKYLAMINE PODDARMENTMcap ₹120 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	101.5	73.5	112.3
Other Income	3.0	3.2	4.5
Total Income	104.5	76.6	116.8
Expenses
+ Cost of Materials Consumed	69.1	48.5	91.3
+ Changes in Inventories	-6.1	2.4	-16.1
+ Employee Benefit Expense	8.4	8.2	8.1
+ Finance Costs	5.1	7.0	9.1
+ Depreciation & Amortisation	2.5	4.8	7.7
+ Other Expenses	23.3	10.6	11.6
Total Expenses	102.3	81.6	111.7
EBITDA	6.7	3.7	17.5
EBIT	4.2	-1.1	9.7
Profit
PBT before Exceptional Items	2.1	-5.0	5.0
Pretax Income	2.1	-5.0	5.0
+ Current Tax	1.3	0.0	0.0
+ Deferred Tax	-0.2	2.1	2.4
Tax Expense	1.0	2.1	2.5
Net Income	1.1	-7.1	2.6
+ Net Income — Continuing Ops	1.1	-7.1	2.6
+ Other Comprehensive Income	-0.0	0.1	0.1
Total Comprehensive Income	1.1	-7.0	2.7
Per Share
Basic EPS	0.52	-6.00	1.45
Diluted EPS	0.52	-5.98	1.45
Other Comprehensive Income — detail
+ Other Comprehensive Income	-0.0	0.1	—
+ Tax on Items NOT to be Reclassified	0.0	—	—
+ Tax on Items to be Reclassified	—	-0.1	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.52	-3.00	0.89
Diluted EPS — Continuing Operations	0.52	-2.99	0.89
Basic EPS — Discontinued Operations	0.00	-3.00	0.56
Diluted EPS — Discontinued Operations	0.00	-2.99	0.56
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	38.4	22.6	37.1
Gross Margin %	37.86	30.72	33.03
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	2.1	-5.0	5.0
Net Income Adj (tax-effected)	1.1	-7.1	2.6
EPS Adj	0.52	-6.00	1.45
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00
Paid Up Equity Capital	21.0	27.3	27.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.